Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026)
Labcorp Holdings' (LH) quarterly Cash from Financing Activities came in at $580.5 million in Q1 2026, up 169.13% year-on-year from $215.7 million in Q1 2025, and up 299.9% quarter-over-quarter from -$290.4 million in Q4 2025.
Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Cash from Financing Activities across 18 years of filings, most recently posting $580.5 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $580.5 million, up 169.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.8 million (up 23.49% YoY), and the FY2025 annual result was -$1.5 billion, down 286.82% from the prior year.
- Cash from Financing Activities came in at $580.5 million for Q1 2026 at Labcorp Holdings, up from -$290.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.5 billion in Q3 2024 to a low of -$1.1 billion in Q3 2023.
- The 5-year median for Cash from Financing Activities is -$267.4 million (2025), against an average of -$86.9 million.
- Across the five-year window, Cash from Financing Activities soared 422.08% in 2023 and tumbled 7076.92% in 2025, its largest moves.
- Labcorp Holdings' Cash from Financing Activities stood at -$372.6 million in 2022, then declined by 19.83% to -$446.5 million in 2023, then fell by 22.44% to -$546.7 million in 2024, then jumped by 46.88% to -$290.4 million in 2025, then jumped by 299.9% to $580.5 million in 2026.
- The last three Cash from Financing Activities figures came in at $580.5 million (Q1 2026), -$290.4 million (Q4 2025), and -$59.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Labcorp Holdings | 22.31 Bn | 21.34 Bn | 1.01 Bn | 580.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 580.50 Mn |
| Mar 31, 2026 | 580.50 Mn |
| Dec 31, 2025 | -290.40 Mn |
| Dec 31, 2025 | -290.40 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -267.40 Mn |
| Jun 30, 2025 | -267.40 Mn |
| Mar 31, 2025 | -839.70 Mn |
| Mar 31, 2025 | -839.70 Mn |
| Dec 31, 2024 | -546.70 Mn |
| Dec 31, 2024 | -546.70 Mn |
| Sep 30, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | -210.00 Mn |
| Jun 30, 2024 | -210.00 Mn |
| Mar 31, 2024 | -11.70 Mn |
| Mar 31, 2024 | -11.70 Mn |
| Dec 31, 2023 | -446.50 Mn |
| Dec 31, 2023 | -446.50 Mn |